BTSG
BrightSpring Health Services, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
60.08
▲ 0.55 (0.92%)
MARKET · —
Price
Open
59.48
Prev close
59.53
Day high
60.65
Day low
58.80
Volume
1.52M
Market cap
$11.65B
P/E (TTM)
52.56
52W range
22.86 – 73.75
Trailing performance
Returnvs SPY
1W
-4.60%
-3.2%
1M
-15.71%
-19.4%
3M
+1.52%
-1.6%
6M
+43.38%
+32.3%
YTD
+57.20%
+44.9%
1Y
+149.13%
+129.1%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$11.65B
Enterprise value$13.98B
Revenue (TTM)$14.37B
Gross profit$1.78B
EBITDA$626.82M
Net income$248.52M
EPS (TTM)$1.12
Free cash flow$1.03B
Total cash$550.38M
Total debt$2.39B
Book value / share$9.94
Shares outstanding197.86M
Float150.40M
Short % of float6.59%
Dividend yield—
Beta (5Y)1.88
Valuation & profitability ratios
Trailing P/E52.56
Forward P/E25.84
PEG ratio—
Price / sales—
Price / book5.92
EV / revenue0.97
EV / EBITDA22.30
Gross margin12.38%
Operating margin3.37%
Profit margin2.55%
Return on equity13.04%
Return on assets4.88%
Debt / equity116.01
Current ratio1.59
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $12.91B | $11.27B | $8.83B | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $190.67M | -$18.06M | -$154.60M | -$53.91M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $190.67M | -$18.06M | -$154.60M | -$53.91M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.40 | 0.45 | +13.0% |
| Mar 2026 | 0.31 | 0.39 | +26.1% |
| Dec 2025 | 0.35 | 0.33 | -4.7% |
| Sep 2025 | 0.26 | 0.30 | +13.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.47 | 16 | $3.87B | +16.0% |
| Next quarter | 0.51 | 16 | $4.02B | +13.1% |
| Current year | 1.82 | 17 | $15.36B | +19.0% |
| Next year | 2.28 | 17 | $17.42B | +13.4% |
Analyst targets & ownership
Mean target$78.94
High target$90.00
Low target$70.00
Implied upside31.39%
Analyst count17
ConsensusSTRONG BUY
Strong buy / Buy3 / 15
Hold0
Sell / Strong sell0 / 0
Held by insiders3.13%
Held by institutions108.30%
Institutions holding577
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
-33.94M
Net selling
Buy transactions
16
1.06M shares
Sell transactions
8
35.00M shares
Net transactions
+24
Buys less sells
Sell : buy shares
33.1 : 1
Heavily one-sided
Insider-held shares
6.44M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 11, 26 | SHAH NIGAM H Director |
STOCK | 4.01K | $0 | Direct |
| Jun 5, 26 | ROUSSEAU JON B Chief Executive Officer |
SELL | 260.00K | $15.28M | |
| Jun 5, 26 | KKR GROUP PARTNERSHIP, L.P. Beneficial Owner of more than 10% of a Class of Security |
SELL | 14.67M | $857.49M | Indirect |
| Jun 5, 26 | PHIPPS JENNIFER A Chief Financial Officer |
SELL | 35.00K | $2.06M | Direct |
| Jun 5, 26 | NALLEY LISA A Officer |
SELL | 35.00K | $2.06M | Direct |
| Jun 5, 26 | NALLEY LISA A Officer |
CONVERSION | 35.00K | $222.95K | Direct |
| Jun 5, 26 | PHIPPS JENNIFER A Chief Financial Officer |
CONVERSION | 35.00K | $222.95K | Direct |
| Jun 5, 26 | ROUSSEAU JON B Chief Executive Officer |
CONVERSION | 260.00K | $1.66M | |
| Jun 5, 26 | KKR GROUP PARTNERSHIP, L.P. Beneficial Owner of more than 10% of a Class of Security |
STOCK | 60.19K | $0 | Indirect |
| May 5, 26 | KIRTLEY OLIVIA F Director |
STOCK | 4.98K | $0 | Direct |
| May 5, 26 | WICKS TIMOTHY A Director |
STOCK | 4.98K | $0 | Direct |
| May 5, 26 | MILLER STEVEN B Director |
STOCK | 4.98K | $0 | Direct |
| Mar 5, 26 | ROUSSEAU JON B Chief Executive Officer |
STOCK | 186.84K | $0 | Direct |
| Mar 5, 26 | PHIPPS JENNIFER A Chief Financial Officer |
STOCK | 53.38K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARNES ROBERT ALLEN |
Officer | 39.27K | Sale |
GREENWELL SCOTT A. |
Officer | 36.86K | Stock Award(Grant) |
KIRTLEY OLIVIA F |
Director | 37.00K | Stock Award(Grant) |
KKR GROUP PARTNERSHIP, L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
MCMAUDE MICHAEL A |
Officer | 207.59K | Sale |
NALLEY LISA A |
Officer | 131.95K | Sale |
PHIPPS JENNIFER A |
Chief Financial Officer | 250.22K | Sale |
ROUSSEAU JON B |
Chief Executive Officer | — | Sale |
WALGREENS BOOTS ALLIANCE, INC. |
Unknown | — | Sale |
YOWLER JENNIFER |
Officer | 75.40K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
59.86
+0.37% from price
SMA 20
62.71
-6.13% from price
SMA 50
66.27
-11.17% from price
SMA 100
59.35
+1.24% from price
SMA 200
48.76
+20.73% from price
EMA 12
60.71
-1.04% from price
EMA 26
62.90
-4.48% from price
EMA 50
63.13
-4.83% from price
RSI (14)
39.5
Neutral
MACD (12,26,9)
-2.18
Hist -0.26
ATR (14)
2.51
4.26% of price
Realised vol 30D
70.9%
Annualised
Bollinger upper
72.10
20, 2σ
Bollinger lower
53.33
20, 2σ
50 / 200 cross
Golden
66.27 vs 48.76
Trend bias
Above 200
+20.73%
Risk profile
Beta vs SPY
1.37
More volatile than market
Correlation to SPY
0.40
Loosely linked
Realised vol 30D
70.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-20.6%
Peak to trough
Max drawdown 5Y
-35.6%
Peak to trough
ATR 14
2.51
4.26% of price
Beta (reported)
1.88
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.90
Call-heavy session
Put / call open interest
2.63
Positioning, not flow
Max pain
55.00
-6.6% from spot
ATM implied vol
43.9%
Nearest strike to spot
Skew (10% OTM)
-0.1%
Calls bid over puts
Call volume
180
Contracts, this expiry
Put volume
162
Contracts, this expiry
Heaviest call OI
70.00
540 contracts
Heaviest put OI
55.00
4.46K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
BrightSpring Stock Up Nearly 59% YTD: Can Its Growth Story Continue?
Zacks · 1d ago
1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges
StockStory · 2d ago
2 Profitable Stocks with Solid Fundamentals and 1 We Ignore
StockStory · 4d ago
2 of Wall Street’s Favorite Stocks on Our Watchlist and 1 That Underwhelm
StockStory · 6d ago
Should BrightSpring Health Services (BTSG) Be Revalued As Earnings And Guidance Shift?
Simply Wall St. · 9d ago
BrightSpring Health Services (BTSG) Stock Still Looks Stretched Following Raised Outlook
Simply Wall St. · 9d ago
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now
Zacks · 10d ago
3 Mid-Cap Stocks with Solid Fundamentals
StockStory · 10d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.